Colon cancer study aims to improve treatment for older patients
NCT ID NCT04416490
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows over 2,000 Korean patients with stage II or III colon cancer after surgery to see which chemotherapy treatments they actually receive and how they fare. Unlike typical clinical trials, it includes older adults and reflects real-world medical practice. The goal is to gather data that could lead to better, more personalized treatment guidelines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors tailor chemotherapy after colon cancer surgery, especially for older patients who are often left out of clinical trials.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new drug or cure. Results may not apply outside of Korea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yonsei University Health System, Severance Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test tell who needs more cancer treatment?
- Can adding cetuximab to chemotherapy prevent colon cancer return?
- Can an arthritis drug boost chemo for colon cancer?
- Blood test may spare some colon cancer patients from chemo
- New genetic test may predict colon cancer return
- DNA-Guided chemo aims to stop colon cancer return